BioQ Pharma to Present at the UBS Global Healthcare Conference

SAN FRANCISCO, May 16, 2017 -- BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the UBS Global Healthcare Conference to be held in New York City from May 22nd to May 24th, 2017.

Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Tuesday, May 23rd at 2:00 p.m. Eastern Daylight Time.

About BioQ Pharma

BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, Galen Limited, and West Pharmaceutical Services.  

BioQ Pharma Contact Information:

Josh Kriesel  
President and CEO 
415-336-6496 

Ron Pauli 
Chief Financial Officer 
415-889-7707

Media: 
Stephanie Carrington 
Integrated Corporate Relations, Inc (ICR) 
[email protected] 
646-277-1282